Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
17.99
-3.97 (-18.08%)
Nov 1, 2024, 4:00 PM EDT - Market closed

Myriad Genetics Statistics

Total Valuation

MYGN has a market cap or net worth of $1.63 billion. The enterprise value is $1.68 billion.

Market Cap 1.63B
Enterprise Value 1.68B

Important Dates

The next confirmed earnings date is Thursday, November 7, 2024, after market close.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

MYGN has 90.82 million shares outstanding. The number of shares has increased by 7.39% in one year.

Shares Outstanding 90.82M
Shares Change (YoY) +7.39%
Shares Change (QoQ) +0.78%
Owned by Insiders (%) 2.21%
Owned by Institutions (%) 96.60%
Float 83.27M

Valuation Ratios

PE Ratio n/a
Forward PE 122.38
PS Ratio 1.96
Forward PS 1.86
PB Ratio 2.21
P/FCF Ratio n/a
PEG Ratio 2.15
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.09
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.19.

Current Ratio 1.96
Quick Ratio 1.44
Debt / Equity 0.19
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -32.28

Financial Efficiency

Return on equity (ROE) is -21.03% and return on invested capital (ROIC) is -7.08%.

Return on Equity (ROE) -21.03%
Return on Assets (ROA) -5.68%
Return on Capital (ROIC) -7.08%
Revenue Per Employee $297,111
Profits Per Employee -$57,481
Employee Count 2,700
Asset Turnover 0.71
Inventory Turnover 10.21

Taxes

Income Tax -1.40M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +15.47% in the last 52 weeks. The beta is 1.94, so MYGN's price volatility has been higher than the market average.

Beta (5Y) 1.94
52-Week Price Change +15.47%
50-Day Moving Average 25.57
200-Day Moving Average 23.83
Relative Strength Index (RSI) 22.28
Average Volume (20 Days) 730,277

Short Selling Information

The latest short interest is 4.49 million, so 4.95% of the outstanding shares have been sold short.

Short Interest 4.49M
Short Previous Month 4.19M
Short % of Shares Out 4.95%
Short % of Float 5.40%
Short Ratio (days to cover) 6.48

Income Statement

In the last 12 months, MYGN had revenue of $802.20 million and -$155.20 million in losses. Loss per share was -$1.78.

Revenue 802.20M
Gross Profit 554.10M
Operating Income -103.30M
Pretax Income -156.60M
Net Income -155.20M
EBITDA -49.00M
EBIT -103.30M
Loss Per Share -$1.78
Full Income Statement

Balance Sheet

The company has $97.30 million in cash and $143.30 million in debt, giving a net cash position of -$46.00 million or -$0.51 per share.

Cash & Cash Equivalents 97.30M
Total Debt 143.30M
Net Cash -46.00M
Net Cash Per Share -$0.51
Equity (Book Value) 740.50M
Book Value Per Share 8.15
Working Capital 142.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$92.80 million and capital expenditures -$32.80 million, giving a free cash flow of -$125.60 million.

Operating Cash Flow -92.80M
Capital Expenditures -32.80M
Free Cash Flow -125.60M
FCF Per Share -$1.38
Full Cash Flow Statement

Margins

Gross margin is 69.07%, with operating and profit margins of -12.88% and -19.35%.

Gross Margin 69.07%
Operating Margin -12.88%
Pretax Margin -19.52%
Profit Margin -19.35%
EBITDA Margin -6.11%
EBIT Margin -12.88%
FCF Margin -17.61%

Dividends & Yields

MYGN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.39%
Shareholder Yield -7.39%
Earnings Yield -9.50%
FCF Yield -7.69%
Dividend Details

Analyst Forecast

The average price target for MYGN is $28.18, which is 56.64% higher than the current price. The consensus rating is "Buy".

Price Target $28.18
Price Target Difference 56.64%
Analyst Consensus Buy
Analyst Count 12
Revenue Growth Forecast (5Y) 7.51%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on March 26, 2009. It was a forward split with a ratio of 2:1.

Last Split Date Mar 26, 2009
Split Type Forward
Split Ratio 2:1

Scores

MYGN has an Altman Z-Score of 2.71 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.71
Piotroski F-Score 4